# Geropharm opens new insulin pen assembly line in Obolensk

Russian pharmaceutical company Geropharm invested 163 million rubles to open a new assembly line for insulin injection pens at its facility in Obolensk, Moscow region. The line adds capacity of 7 million pens per year, increasing total capacity to 21 million pens annually.

- Type: Expansion
- Announced: 2023-08-23
- Where: Obolensk, Moscow region, Russia
- Value: $1.70M (163.0M RUB)
- Starts operating: 23 Aug 2023
- Status: completed
- Capacity: 7 million pens per year
- Products: insulin injection pens
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Geropharm](https://endata.com/companies/27090.md)

## Sources

- [gxpnews.net](https://gxpnews.net/2023/08/gerofarm-za-163-mln-rublej-otkryla-novyj-uchastok-po-sborke-shpricz-ruchek-s-insulinom/), 2023-08-23: "Производственная мощность предприятия увеличится до 21 млн инъекторов ежегодно"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.